The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis
A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief
An expert talks through the benefits, limits and unresolved questions of an evolving technology
How we’re efficiently educating patients and care partners about treatment goals, logistics, risks and benefits
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel Cleveland Clinic project is fueled by a $1 million NIH grant
Large NIH-funded investigation is exploring this understudied phenomenon
New guidelines from Brain Trauma Foundation urge early and aggressive treatment
Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors
Novel approach dramatically reduces the need for real-world data
Initial results show good accuracy of scalable, low-cost tool for flagging cognitive decline
Advertisement
Advertisement